The company’s suzetrigine is one of the most-watched medicines across all the drug pipelines in the biotech sector.

A new study has found a potential breakthrough in the treatment of chronic pain and doesn't rely on addictive opiate ...

Researchers have made a discovery regarding the TRPV1 (transient receptor potential vanilloid 1) ion channel and its role in pain perception. The study reveals how solvent molecules can modulate pain ...

Boosting the endocannabinoid 2-AG in the brain can counteract opioid addiction while preserving their pain relief, a Weill ...

New British research shows that too much of a good medication can be a bad thing.In the study, repeated doses of para ...

A team of researchers from Weill Cornell Medicine and the Burke Neurological Institute has developed a groundbreaking drug ...

A major breakthrough in our understanding of pain has been revealed in a collaborative study led by a Leeds scientist, opening the door to new ways of tackling long term pain without harmful and ...

The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for TNX-102 SL (cyclobenzaprine HCL sublingual tablets) for the management of fibromyalgia.

Pain has really been out of favor in the industry up until very recently,” said John Mulcahy, SiteOne Therapeutics’ CEO. The ...

Mixed results from a study focused on lower back pain left analysts wanting as well as confused about Vertex's plans to forge ...